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Case Report
Endoscopic Cricopharyngeal Myotomy for Management of
Cricopharyngeal Achalasia in an 18-Month-Old Child
Robert Chun, MD; Mathew Sitton, MD; Neelesh A. Tipnis, MD; Joan C. Arvedson, PhD;
Aparna Rao, MD; Jason Dranove, MD; David J. Brown, MD
A 6–month–old patient presented with dysphagia and failure to thrive. Video fluoroscopic swallow study (VFSS), esopha-
gogastroduodenoscopy, and manometry were diagnostic for CA. A gastrostomy tube was placed at 8 months. Botulinum toxin
injection improved symptoms, but within 10 weeks symptoms returned.
At 18 months, an uncomplicated endoscopic CPM was performed. A postoperative VFSS demonstrated cricopharyngeal
bar resolution. Within 3 months, patient was feeding orally without a G tube.
Pediatric CPA treatment options consist of dilation, botox, and transcervical CPM. To our knowledge, this is the youngest
patient treated with endoscopic CPM. Intraoperative video and photographs are presented.
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INTRODUCTION
Cricopharyngeal achalasia (CA) is a failure of the
upper esophageal sphincter to open upon initiation of
the pharyngeal swallow. CA is typically characterized by
dysphagia, choking, and poor weight gain. Video fluoro-
scopic swallow studies (VFSS), manometry, clinical
swallow evaluation, and endoscopic esophagoscopy are
all useful in the diagnosis.
Treatment options vary from observation, botuli-
num toxin injection, mechanical dilation, and cervical
cricopharyngeal myotomy (CPM).1–4 In 2005, Baumen
described the use of botox in an infant for CA.1 Messner
recently described a series of seven botulinum toxin
injections in three infants with CA.2 In this series, the
mean follow-up was 22 months. The time between botu-
linum toxin injections was on average every 3.3 months.
The only complication was one hospital readmission for
self—resolving aspiration.
Dilation of the upper esophageal sphincter has been
described as a noninvasive treatment option for CA. Bal-
loon dilation for CA was recently described for a 1–day–
old newborn by Erdeve.1 Following four dilations, the
patient’s manometry and swallow were normal but fol-
low-up was limited to 1 month after the last dilation.
Other cases of balloon dilation have proceeded to surgi-
cal cricopharyngeal myotomy following limited benefit to
dilation.3 While balloon dilation can improve CA, reoc-
currence of symptoms may require surgical division of
the cricopharyngeal muscle.
Cervical CPM was described by Brooks and col-
leagues in a series of five patients since 1976.4 In their
series, patients presented from birth to 6 months with
dysphagia and recurrent episodes of lower respiratory
tract infections and failure to thrive. All patients did
well without complications. They had good outcomes
with long term follow-up (2–14 years). However, cervical
cricopharyngeal myotomy does have associated risks
including infection, hemorrhage, inadequate sectioning
of the UES, transient unilateral vocal cord paralysis,
recurrent laryngeal nerve damage, esophageal mucosa
perforation, fistula formation, and mediastinitis.5
Endoscopic CPM was described by Pittman and
Weissbrod, who discussed the surgical techniques and im-
portance of leaving the buccopharyngeal fascia intact to
prevent violation into the retropharyngeal space.6 Dauer
and Brondo, with a separate series of patients, discussed
the management of adult CA with endoscopic laser CPM,
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symptomatic improvement, and no complications of
mediastinitis.7–8
At the time of this publication, our case represents
the youngest published patient to undergo endoscopic
CPM in the treatment of CA. This case report will dis-
cuss multidisciplinary management in diagnosis and
treatment.
CASE REPORT
A 6-month-old infant born at term presented to an
outside institution with a lifelong history of choking
with nipple feeds, and frequent respiratory illnesses
requiring medical attention beginning in early infancy.
This infant was initially bottle fed, but despite multiple
formula changes, introduction of solids at 6 months of
age, and aggressive gastroesophageal reflux treatment
with proton pump inhibitors, his dysphagia continued
and his weight fell below the third percentile by 8
months of age. The patient otherwise met all develop-
mental milestones for his age. There were no signs of a
global neuromuscular or central nervous system abnor-
mality. The patient had a normal MRI of brain, ruling
out a Chiari malformation, which can be a cause for pe-
diatric dysphagia. Videofluoroscopic swallow studies
(VFSS) had been completed at outside institutions,
according to the parents. They stated that their child
aspirated on liquid with bottle feedings as an infant and
on puree with spoon feeding beginning about 6 months
of age. An esophagogastroduodenoscopy revealed diffi-
culty intubating the upper esophageal sphincter,
necessitating change to a neonatal endoscope, which did
pass with success; biopsies performed revealed normal
esophageal mucosa. This supported the suspicion of CA.
Due to continued dysphagia, intermittent aspiration,
and inadequate weight gain, a gastrostomy tube was
placed at 8 months. At 11 months of age, this infant
underwent botulinum toxin injection into the cricophar-
yngeal musculature. A repeat VFSS showed resolution
of the cricopharyngeal bar and no aspiration, with sig-
nificant clinical improvement. Unfortunately within 10
weeks his dysphagia returned, repeat VFSS showed
return of CA, and he resumed his NPO status except for
minimal tastes of puree by spoon.
The patient’s care was transferred to the Children’s
Hospital of Wisconsin at 16 months of age. He was eval-
uated in the interdisciplinary aerodigestive and voice
clinic with an otolaryngologist, gastroenterologist, pul-
monologist, and speech-language pathologist. These
professionals consult together to diagnose, manage, and
treat patients in an interdisciplinary fashion with one
visit for the patient and family. The patient underwent a
coordinated EGD, bronchoscopy, and endoscopic CPM
following the initial clinic visit.
Fig. 1. Figure demonstrates high resolution esophageal manome-
try for our patient. The brackets demarcate the regions of the
upper digestive tract: pharynx, upper esophageal sphincter (UES)
and proximal esophagus. The colors represent contraction pres-
sure: blue indicating low and red indicating high. The white arrows
in the patients swallow indicate initiation of the swallow. The red
arrow in the patients swallow indicates opening of the UES to
allow passage of contents from the pharynx to the esophagus
(blue channel). In this patient, the opening is brief and inconsistent
(not seen in the other 3 swallows shown here).
Fig. 2. Top Panel: Microscopic view of cricopharyngeal bar under
suspension. Arrow demonstrates cricopharyngeal muscle; Middle
Panel: Laser resection of muscle fibers of cricopharyngeus muscle
with counter retraction with laryngeal probe; Lower Panel: Com-
pleted cricopharyngeal myotomy with resection to buccopharyng-
eal fascia with visualization of fat and nodes in retropharyngeal
space.
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A video fluoroscopic swallow study (VFSS) was per-
formed with findings consistent for CA. The child was
seated on the Multiple Application Multiple Articulation
(MAMA) chair in upright position for a lateral view of
oral, pharyngeal, and upper esophageal phases of swal-
lowing. The child’s mother presented a spoon with very
thin liquid (apple juice, 4 presentations), thickened liq-
uid (nectar consistency apple juice, 3 presentations), and
pureed food (pudding, 3 presentations). Child was calm
and cooperative, until the final presentation of pudding
when he fussed. Findings were reviewed with parents by
a speech-language pathologist (SLP) and radiologist. The
findings were then reviewed independently by two SLPs
(7 and 13 years experience in conducting, reading, and
interpreting VFSS with pediatric patients) with consen-
sus reached for objective findings.
In summary, the child demonstrated functional
bolus formation and oral transit. A borderline delay in
pharyngeal swallow initiation was noted only rarely
when material was seen in the valleculae and pyriform
sinuses prior to initiation of a pharyngeal swallow. Trace
silent aspiration was seen just to the underside of the
vocal folds on very thin liquid, which was ejected from
the airway upon exhalation. Thickened liquid and puree
were seen along the lower posterior pharyngeal wall, in
pyriform sinuses, and on the upper esophageal sphincter
(UES) following swallows when the boluses did not move
completely through the UES. Aspiration occurred on the
residue occasionally with no cough. The primary finding
in the upper esophagus was a prominent cricopharyng-
eal bar that did interfere with bolus passage at times.
The child produced additional ‘‘dry’’ swallows and
cleared the pharynx of the residue which moved through
the esophagus. He had no deficits in tongue base retrac-
tion with no residue in the valleculae post swallows. The
pharyngeal residue related more directly to upper esoph-
ageal phase than to pharyngeal phase swallowing with a
small amount of residue in the lower pharynx. Retro-
grade movement was noted occasionally from the
esophagus up into the pharynx.
The endoscopic CPM was performed with microsus-
pension laryngoscopy with exposure of the cricopharygeal
muscle by suspending a parson’s laryngoscope posterior
to the larynx. An orogastric tube was placed to facilitate
laryngoscopic positioning and exposure and was removed
prior to lasering. CO2 laser was used at a setting of 7
watts, scan mode with a 0.7-mm size spot with a 0.3 sec-
ond delay. An angled laryngeal retractor was used to
provide counter tension on the muscle fibers to facilitate
dissection. Layer by layer dissection was performed until
the gray translucent buccopharyngeal fascia was visual-
ized with the underlying fat and nodes of the
retropharyngeal space could be seen.
A postoperative VFSS within 24 hours after the
procedure demonstrated resolution of the cricopharyng-
eal bar, and only one trace occasional minimal
aspiration just prior to the second swallow of very thin
liquid, due to slight delay in initiating a pharyngeal
swallow. A small amount of residue was seen in the
pharynx, which was much less than preoperatively, and
the child cleared the residue with a follow-up swallow. A
pharyngeal defect was noted secondary to the CPM, and
the patient developed no signs or symptoms of infection.
Nine months post surgery, the patient has had no recur-
rence of symptoms, his gastrostomy tube has been
removed, he is taking a regular diet with no restrictions,
and his weight is steady at the 50th percentile.
DISCUSSION
Cricopharyngeal achalasia (CA) is an uncommon
cause of dysphagia in neonatal and pediatric popula-
tions. The etiology of CA is likely idiopathic and is
secondary to a failure of the upper esophageal sphincter
(UES) to relax and open sufficiently for a bolus to pass
through the UES during a swallow.1
Upper esophageal endoscopy identified a narrow cri-
copharyngeal luminal diameter. While positive response
to previous botulinum toxin suggests CA, prior to a defin-
itive operative treatment, manometric studies can
functionally confirm a diagnosis of CA. High-resolution
esophageal manometry was performed and noted both
elevated resting pressure (70 mmHg) and poor relaxation
of the cricopharyngeal musculature (See Fig. 2).
Fig. 3. Left Panel: Preoperative
VFSS demonstrating cricopharyng-
eal bar; Right Panel: Resolution of
cricopharyngeal bar.
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Pharyngeal contraction pressure and esophageal body
function were normal, which is an important finding to
support a positive prognosis for oral feeding gains antici-
pated following surgery. Manometry demonstrated a
bolus permissive period of only about 0.1 second, with
normal about 0.3–0.4 seconds (in adults) in duration.9
These findings are consistent with CA. Previous MRI of
the brain failed to identify posterior fossa abnormalities
that can be associated with CA.
Upper esophageal endoscopy ruled out concomitant
diseases such as reflux esophagitis and eosinophilic
esophagitis (EoE) via biopsy of the esophagus. GER has
been shown to cause hyperactive cricopharyngeus mus-
cle and is important to aggressively treat prior to
CPM.10–12 Furthermore, untreated EoE may complicate
postoperative swallowing and healing as it is known to
complicate aerodigestive procedures such as laryngotra-
cheal reconstruction outcomes.13
Due to this patient’s history of aspiration and RSV
bronchiolitis, there were long-term concerns for his re-
spiratory morbidity with continued feeding difficulty and
aspiration. A flexible bronchoscopy was performed and
revealed no anatomical abnormalities.
Botulinum toxin only temporarily resolved the
child’s symptoms. Parents expressed a desire for defini-
tive long-lasting treatment, surgical options were
considered. These options included external versus endo-
scopic CPM. In contrast to the risks of transcervical
cricopharyngeal myotomy, the risks of endoscopic crico-
pharyngeal myotomy approach include restenosis,
retropharyngeal space infection and mediastinitis, ther-
mal injury, fistula formation, and subcutaneous
emphysema. Endoscopic CPM offers a minimally inva-
sive approach without risk of laryngeal nerve injury, but
possibly has higher risk of retropharyngeal space viola-
tion and infection. Endoscopic CPM may possibly
provide definitive treatment under a single anesthetic,
while other methods of dilation and botulinum toxin
may take repetitive procedures for treatment.
The endoscopic CPM was performed with CO2 laser.
Intraoperative and postoperative antibiotics and proton
pump inhibitors were given following the procedure.
Decadron (0.5mg/kg) was given once due to concerns for
post op laryngeal edema. The risks and benefits of intra-
operative steroid use should be considered in each
individual case, weighing benefits of decreasing laryn-
geal edema versus disadvantages of immunosuppression
and hindrance to wound healing. It is essential to keep
the buccopharyngeal fascia layer intact to prevent viola-
tion into the retropharyngeal space and possible
subsequent infection. The buccopharyngeal is a glisten-
ing gray fascia that is discernable from the overlying
cricopharyngeal muscle and from the underlying fat of
the retropharyngeal space. Because the retropharyngeal
space descends into the anterior mediastinum, violation
of the buccopharyngeal fascia can possibly lead to media-
stinal infection.
The child’s follow-up VFSS was completed about 24
hours after the myotomy (Fig. 7). A cricopharyngeal bar
was not prominent. Boluses moved through the UES
with no restriction. Trace aspiration on very thin liquid
was noted one time just prior to initiation of a pharyn-
geal swallow, due to a timing problem and not a
cricopharyngeal deficit. A small ‘‘pouch’’ was noted at
the posterior UES, with a small amount of barium con-
trast going retrograde in the submucosal space between
the mucosa and buccopharyngeal fascia, but no barium
entered or descended into the retropharygeal space dis-
tally. This may be due to the barium reaching the lower
limit of the dissection and ‘‘refluxing’’ up into the
submucosal space superiorly. The fact that the retro-
pharyngeal space is a true and not potential space in
children may also explain why the barium refluxed
superficial to the buccopharyngeal fascia and retrophar-
yngeal space. Follow-up VFSS 2, 4, and 6 months after
procedure showed no signs of restenosis.
CONCLUSION
Infants and children with cricopharyngeal achalasia
have multiple factors underlying their dysphagia, not
simply upper esophageal sphincter dysfunction. While
botox, dilation, and cervical CPM may be used for treat-
ment of CA symptoms, our case demonstrates that
endoscopic CPM is possible in the age group and can
successfully resolve symptoms. While a large surgical
cohort would be ideal to access morbidity, long-term suc-
cess, and complications of pediatric endoscopic CPM, our
case report suggests that endoscopic CPM may be per-
formed with low morbidity and decreased anesthesia
exposure compared to other methods. Long-term safety
and efficacy in treatment is unknown until larger sam-
ples of pediatric endoscopic CPM can be performed and
followed.
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